MedPath

Effect of relaxation on Patients with multiple sclerosis

Phase 2
Conditions
Multiple sclerosis.
Demyelinating diseases of the central nervous system
Registration Number
IRCT201302109759N3
Lead Sponsor
Vice-chancellor of Research and Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

(a) certain diagnosis of multiple sclerosis by neurologist; (b) age between 20-45; (c) not to be in acute phase of disease; (d) EDSS (Expanded Disability Status Scale) which is equal or less than 4/5 according to neurologist's view; (e) to have pain and fatigue symptoms. Exclusion criteria: (a) lack of ability to participate in the relaxation sessions for any reason; (b) to be hospitalized in hospital.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain. Timepoint: Before and after intervention. Method of measurement: Visual pain Scale.;Fatigue. Timepoint: Before and after intervention. Method of measurement: Fatigue Severity Scale for patient with multiple sclerosis.;Quality of life. Timepoint: Before and after intervention. Method of measurement: MSQoL-54 questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath